Showing results 1 to 1 of 1
Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells Yun, Sun-Mi; Jung, Kyung Hee; Lee, Hyunseung; Son, Mi Kwon; Seo, Ju-Hyeon; Yan, Hong Hua; Park, Byung Hee; et al, CANCER LETTERS, v.331, no.2, pp.250 - 261, 2013-05 |
Discover